{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,22]],"date-time":"2026-10-22T19:34:55Z","timestamp":1792697695481,"version":"4.5.0"},"reference-count":21,"publisher":"Springer Science and Business Media LLC","issue":"3","license":[{"start":{"date-parts":[[2020,9,28]],"date-time":"2020-09-28T00:00:00Z","timestamp":1601251200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2020,9,28]],"date-time":"2020-09-28T00:00:00Z","timestamp":1601251200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Osteoporos Int"],"published-print":{"date-parts":[[2021,3]]},"DOI":"10.1007\/s00198-020-05637-0","type":"journal-article","created":{"date-parts":[[2020,9,28]],"date-time":"2020-09-28T17:03:01Z","timestamp":1601312581000},"page":"559-564","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":11,"title":["Therapeutic efficacy of zoledronic acid combined with calcitriol in elderly patients receiving total hip arthroplasty or hemiarthroplasty for osteoporotic femoral neck fracture"],"prefix":"10.1007","volume":"32","author":[{"given":"K.","family":"Zhu","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J.","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"C.","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Z.","family":"Zhao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J.","family":"Gao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"X.","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"X.","family":"Xia","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"X.","family":"Xu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"T.","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J.","family":"Guan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2020,9,28]]},"reference":[{"key":"5637_CR1","doi-asserted-by":"publisher","first-page":"441","DOI":"10.1016\/j.injury.2016.12.013","volume":"48","author":"JH Yoo","year":"2017","unstructured":"Yoo JH, Kim KT, Kim TY, Hwang JH, Chang JD (2017) Postoperative fever after hemiarthroplasty in elderly patients over 70 years of age with displaced fe moral neck fracture: necessity of routine workup? Injury 48:441\u2013446","journal-title":"Injury"},{"key":"5637_CR2","doi-asserted-by":"publisher","first-page":"741","DOI":"10.1002\/acr.24171","volume":"72","author":"MI Danila","year":"2020","unstructured":"Danila MI, Saag KG (2020) Imminent fracture risk: a call to action for rheumatologists. Arthritis Care Res (Hoboken) 72:741\u2013743","journal-title":"Arthritis Care Res (Hoboken)"},{"key":"5637_CR3","doi-asserted-by":"publisher","first-page":"364","DOI":"10.1016\/s0140-6736(18)32112-3","volume":"393","author":"JE Compston","year":"2019","unstructured":"Compston JE, McClung MR, Leslie WD (2019) Osteoporosis. Lancet 393:364\u2013376. https:\/\/doi.org\/10.1016\/s0140-6736(18)32112-3","journal-title":"Lancet"},{"key":"5637_CR4","doi-asserted-by":"publisher","first-page":"1","DOI":"10.3310\/hta15suppl1-01","volume":"15","author":"C Carroll","year":"2011","unstructured":"Carroll C, Stevenson M, Scope A et al (2011) Hemiarthroplasty and total hip arthroplasty for treating primary intracapsular fracture of the hip: a systematic review and cost-effectiveness analysis. Health Technol Assess 15:1\u201374","journal-title":"Health Technol Assess"},{"issue":"4","key":"5637_CR5","doi-asserted-by":"publisher","first-page":"969","DOI":"10.3390\/jcm9040969","volume":"9","author":"S Vasta","year":"2020","unstructured":"Vasta S, Papalia R, Torre G et al (2020) The influence of preoperative physical activity on postoperative outcomes of knee and hip arthroplasty surgery in the elderly: a systematic review. J Clin Med 9(4):969","journal-title":"J Clin Med"},{"key":"5637_CR6","doi-asserted-by":"publisher","first-page":"2017","DOI":"10.1001\/jama.2019.15781","volume":"322","author":"KE Ensrud","year":"2019","unstructured":"Ensrud KE, Crandall CJ (2019) Bisphosphonates for postmenopausal osteoporosis. Jama 322:2017","journal-title":"Jama"},{"key":"5637_CR7","doi-asserted-by":"publisher","first-page":"1799","DOI":"10.1056\/NEJMoa074941","volume":"357","author":"KW Lyles","year":"2007","unstructured":"Lyles KW, Col\u00ae\u00c6n-Emeric CS, Magaziner JS, et al. (2007) Zoledronic acid and clinical fractures and mortality after hip fracture. N Engl J Med 357:1799\u20131809","journal-title":"N Engl J Med"},{"key":"5637_CR8","doi-asserted-by":"publisher","first-page":"1277","DOI":"10.1007\/s00198-009-1077-9","volume":"21","author":"R Eastell","year":"2010","unstructured":"Eastell R, Lang T, Boonen S et al (2010) Effect of once-yearly zoledronic acid on the spine and hip as measured by quantitative computed tomog raphy: results of the HORIZON Pivotal Fracture Trial. Osteoporos Int 21:1277\u20131285","journal-title":"Osteoporos Int"},{"key":"5637_CR9","first-page":"411","volume":"18","author":"A Mullard","year":"2019","unstructured":"Mullard A (2019) FDA approves first-in-class osteoporosis drug. Nat Rev Drug Discov 18:411","journal-title":"Nat Rev Drug Discov"},{"key":"5637_CR10","doi-asserted-by":"publisher","first-page":"2407","DOI":"10.1056\/NEJMoa1808082","volume":"379","author":"IR Reid","year":"2018","unstructured":"Reid IR, Horne AM, Mihov B, Stewart A, Garratt E, Wong S, Wiessing KR, Bolland MJ, Bastin S, Gamble GD (2018) Fracture prevention with zoledronate in older women with osteopenia. N Engl J Med 379:2407\u20132416","journal-title":"N Engl J Med"},{"key":"5637_CR11","doi-asserted-by":"publisher","first-page":"1581","DOI":"10.1007\/s00198-019-05005-7","volume":"30","author":"W Zhou","year":"2019","unstructured":"Zhou W, Liu Y, Guo X, Yang H, Xu Y, Geng D (2019) Effects of zoledronic acid on bone mineral density around prostheses and bone metabolism markers after primary total hip arthroplasty in females with postmenopausal osteoporosis. Osteoporos Int 30:1581\u20131589. https:\/\/doi.org\/10.1007\/s00198-019-05005-7","journal-title":"Osteoporos Int"},{"key":"5637_CR12","doi-asserted-by":"publisher","first-page":"35","DOI":"10.1016\/j.jbiomech.2018.04.041","volume":"75","author":"E Aro","year":"2018","unstructured":"Aro E, Moritz N, Mattila K, Aro HT (2018) A long-lasting bisphosphonate partially protects periprosthetic bone, but does not enhance initial st ability of uncemented femoral stems: a randomized placebo-controlled trial of women undergoing total hip arthroplasty. J Biomech 75:35\u201345","journal-title":"J Biomech"},{"key":"5637_CR13","doi-asserted-by":"publisher","first-page":"209","DOI":"10.1186\/s12891-017-1577-2","volume":"18","author":"TW Huang","year":"2017","unstructured":"Huang TW, Wang CJ, Shih HN, Chang Y, Huang KC, Peng KT, Lee MS (2017) Bone turnover and periprosthetic bone loss after cementless total hip arthroplasty can be restored by zoledronic acid: a prospective, randomized, open-label, controlled trial. BMC Musculoskelet Disord 18:209","journal-title":"BMC Musculoskelet Disord"},{"key":"5637_CR14","doi-asserted-by":"publisher","first-page":"671","DOI":"10.1016\/j.arth.2012.08.007","volume":"28","author":"DF Scott","year":"2013","unstructured":"Scott DF, Woltz JN, Smith RR (2013) Effect of zoledronic acid on reducing femoral bone mineral density loss following total hip arthropla sty: preliminary results of a prospective randomized trial. J Arthroplast 28:671\u2013675","journal-title":"J Arthroplast"},{"key":"5637_CR15","doi-asserted-by":"publisher","first-page":"1809","DOI":"10.1056\/NEJMoa067312","volume":"356","author":"DM Black","year":"2007","unstructured":"Black DM, Delmas PD, Eastell R, Reid IR, Boonen S, Cauley JA, Cosman F, Lakatos P, Leung PC, Man Z, Mautalen C, Mesenbrink P, Hu H, Caminis J, Tong K, Rosario-Jansen T, Krasnow J, Hue TF, Sellmeyer D, Eriksen EF, Cummings SR, HORIZON Pivotal Fracture Trial (2007) Once-yearly zoledronic acid for treatment of postmenopausal osteoporosis. N Engl J Med 356:1809\u20131822","journal-title":"N Engl J Med"},{"key":"5637_CR16","doi-asserted-by":"publisher","first-page":"389","DOI":"10.1007\/s00198-016-3736-y","volume":"28","author":"T Nakamura","year":"2017","unstructured":"Nakamura T, Fukunaga M, Nakano T, Kishimoto H, Ito M, Hagino H, Sone T, Taguchi A, Tanaka S, Ohashi M, Ota Y, Shiraki M (2017) Efficacy and safety of once-yearly zoledronic acid in Japanese patients with primary osteoporosis: tw o-year results from a randomized placebo-controlled double-blind study (ZOledroNate treatment in Eff icacy to osteoporosis; ZONE study). Osteoporos Int 28:389\u2013398","journal-title":"Osteoporos Int"},{"key":"5637_CR17","doi-asserted-by":"publisher","first-page":"1767","DOI":"10.1002\/jbmr.2847","volume":"31","author":"KJ Bell","year":"2016","unstructured":"Bell KJ, Hayen A, Glasziou P et al (2016) Potential usefulness of BMD and bone turnover monitoring of zoledronic acid therapy among women with osteoporosis: secondary analysis of randomized controlled trial data. J Bone Miner Res 31:1767\u20131773","journal-title":"J Bone Miner Res"},{"key":"5637_CR18","doi-asserted-by":"publisher","first-page":"3141","DOI":"10.1007\/s10067-018-4185-0","volume":"37","author":"LJ Li","year":"2018","unstructured":"Li LJ, Zhang J, Gao P, Lv F, Song YW, Chang XY, Zhao DC, Wang O, Jiang Y, Xing XP, Xia WB, Li M (2018) Clinical characteristics and bisphosphonates treatment of rare pregnancy- and lactation-associated os teoporosis. Clin Rheumatol 37:3141\u20133150","journal-title":"Clin Rheumatol"},{"key":"5637_CR19","doi-asserted-by":"publisher","first-page":"112037","DOI":"10.1016\/j.bone.2019.07.013","volume":"128","author":"J Sibonga","year":"2019","unstructured":"Sibonga J, Matsumoto T, Jones J, Shapiro J, Lang T, Shackelford L, Smith SM, Young M, Keyak J, Kohri K, Ohshima H, Spector E, LeBlanc A (2019) Resistive exercise in astronauts on prolonged spaceflights provides partial protection against spacef light-induced bone loss. Bone 128:112037","journal-title":"Bone"},{"key":"5637_CR20","doi-asserted-by":"publisher","first-page":"284","DOI":"10.1111\/os.12338","volume":"9","author":"Y Ding","year":"2017","unstructured":"Ding Y, Zeng JC, Yin F, Zhang CL, Zhang Y, Li SX, Liu X, Zhang C, Xue QY, Lin H, Pei FX (2017) Multicenter study on observation of acute-phase responses after infusion of zoledronic acid 5 mg in Chinese women with postmenopausal osteoporosis. Orthop Surg 9:284\u2013289","journal-title":"Orthop Surg"},{"key":"5637_CR21","doi-asserted-by":"crossref","unstructured":"Popp AW, Senn R, Curkovic I et al (2017) Factors associated with acute-phase response of bisphosphonate-na\u00efve or pretreated women with osteoporosis receiving an intravenous first dose of zoledronate or ibandronate. Osteoporos Int 28:1995\u20132002","DOI":"10.1007\/s00198-017-3992-5"}],"container-title":["Osteoporosis International"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00198-020-05637-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00198-020-05637-0\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00198-020-05637-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,9,28]],"date-time":"2021-09-28T01:11:41Z","timestamp":1632791501000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00198-020-05637-0"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,9,28]]},"references-count":21,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2021,3]]}},"alternative-id":["5637"],"URL":"https:\/\/doi.org\/10.1007\/s00198-020-05637-0","relation":{},"ISSN":["0937-941X","1433-2965"],"issn-type":[{"value":"0937-941X","type":"print"},{"value":"1433-2965","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,9,28]]},"assertion":[{"value":"22 April 2020","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"10 September 2020","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"28 September 2020","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"All patients provided informed consent about reviewing their medical records and the purpose of the study. The protocol of this prospective single-center study was approved by the institutional review board of The First Affiliated Hospital of Bengbu Medical College in accordance with the principles of the Declaration of Helsinki.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with ethical standards"}},{"value":"None.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflicts of interest"}}]}}